These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6642103)

  • 1. Modeling time-to-tumor data: analysis of the ED01 study.
    Brown KG; Hoel DG
    Fundam Appl Toxicol; 1983; 3(5):458-69. PubMed ID: 6642103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multistage prediction of cancer in serially dosed animals with application to the ED01 study.
    Brown KG; Hoel DG
    Fundam Appl Toxicol; 1983; 3(5):470-7. PubMed ID: 6642104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of agreement among findings of pathologists in ED01 experiment.
    Amato DA; Lagakos SW
    J Natl Cancer Inst; 1988 Aug; 80(12):919-25. PubMed ID: 3398066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-examination of the ED01 study--risk assessment using time.
    Fundam Appl Toxicol; 1981; 1(1):88-123. PubMed ID: 7184778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study.
    Cohen SM; Ellwein LB
    Toxicol Appl Pharmacol; 1990 Jun; 104(1):79-93. PubMed ID: 2360210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously.
    Farmer JH; Kodell RL; Greenman DL; Shaw GW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):55-68. PubMed ID: 7365386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to the society of toxicology task force re-examination of the ED01 study.
    Kodell RL; Gaylor DW; Greenman DL; Littlefield NA; Farmer JH
    Fundam Appl Toxicol; 1983; 3(4):3a-12a. PubMed ID: 6688789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-examination of the ED01 study - adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):67-80. PubMed ID: 7184775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-examination of the ED01 study--technical discussion of the statistical analysis for adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):81-7. PubMed ID: 7184777
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-examination of the ED01 study. Overview.
    Fundam Appl Toxicol; 1981; 1(1):28-63. PubMed ID: 7184773
    [No Abstract]   [Full Text] [Related]  

  • 11. Two-stage and Weibull models for carcinogenesis applied to the ED01 discontinued dosing data.
    Kodell RL; Felton RP
    Environ Health Perspect; 1991 May; 92():155-66. PubMed ID: 1935845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
    Crump KS; Clewell HJ
    Toxicol Sci; 2003 Aug; 74(2):485; author reply 485-6. PubMed ID: 12730607
    [No Abstract]   [Full Text] [Related]  

  • 13. The ED01 study: summary and conclusions.
    Gaylor DW
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):179-83. PubMed ID: 7365380
    [No Abstract]   [Full Text] [Related]  

  • 14. Thresholds of carcinogenicity in the ED01 study.
    Waddell WJ
    Toxicol Sci; 2003 Mar; 72(1):158-63. PubMed ID: 12604845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thresholds of carcinogenicity in the ED01 study.
    Andersen ME; Conolly RB; Gaylor DW
    Toxicol Sci; 2003 Aug; 74(2):486-7; author reply 487-8. PubMed ID: 12874369
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of distributions of time to appearance of tumor and time to death from tumor after appearance in mice fed 2-acetylaminofluorene.
    Kodell RL; Farmer JH; Greenman DL; Frith CH
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):89-102. PubMed ID: 7365388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fitting the two-stage clonal expansion model based on exact hazard to the ED01 data using SAS NLIN.
    Lensing SY; Kodell RL
    Risk Anal; 1995 Apr; 15(2):233-45. PubMed ID: 7597259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dose and time in a long-term, low-dose carcinogenic study.
    Littlefield NA; Farmer JH; Gaylor DW; Sheldon WG
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):17-34. PubMed ID: 7365379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of total dose and dose rate in carcinogenicity studies.
    Littlefield NA; Gaylor DW
    J Toxicol Environ Health; 1985; 15(5):545-50. PubMed ID: 4046064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue binding of 2-acetylaminofluorene in BAlB/c and C57Bl/6 mice during chronic oral administration.
    Jackson CD; Weis C; Shellenberger TE
    Chem Biol Interact; 1980 Oct; 32(1-2):63-81. PubMed ID: 7428117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.